SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Da-biao Chen, You-ming Chen, Jing Liu, Dong-ying Xie, Cui-rong Lu, Zhan-lian Huang, Rui-hua Zhu, Zhi-liang Gao, Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients, Journal of Clinical Virology, 2014, 59, 1, 50

    CrossRef

  2. 2
    Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li, Loss of HBsAg and antiviral treatment: from basics to clinical significance, Hepatology International, 2014, 8, 1, 39

    CrossRef

  3. 3
    Hmin Liu, Xbo Wang, Gang Wan, Zyun Yang, Hui Zeng, Telbivudine Versus Entecavir for Nucleos(t)ide-Naive HBeAg-Positive Chronic Hepatitis B, The American Journal of the Medical Sciences, 2014, 347, 2, 131

    CrossRef

  4. 4
    Rosa María Martín-Mateos, Víctor F. Moreira Vicente, Luis Téllez-Villajos, Concepción García-Sánchez, María Teresa Maroto-Castellanos, Francisco Javier García-Alonso, María Luisa Mateos-Lindemann, Agustín Albillos, Tratamiento de la hepatitis crónica B antígeno e positiva con antivirales orales: experiencia y resultados en la práctica clínica, Gastroenterología y Hepatología, 2014, 37, 5, 280

    CrossRef

  5. 5
    Yingnan Huang, Hao Wu, Shengdi Wu, Da Fu, Yushui Ma, Xizhong Shen, A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B, Digestive Diseases and Sciences, 2013, 58, 3, 815

    CrossRef

  6. You have free access to this content6
    Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski, N. V. Naoumov, Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B, Journal of Viral Hepatitis, 2013, 20, 4
  7. 7
    Jian Liang, Man Jun Jiang, Xin Deng, Xiao Xiao Zhou, Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study, Hepatitis Monthly, 2013, 13, 5

    CrossRef

  8. 8
    Patrick Marcellin, Tarik Asselah, Long-term therapy for chronic hepatitis B: Hepatitis B virus DNA suppression leading to cirrhosis reversal, Journal of Gastroenterology and Hepatology, 2013, 28, 6
  9. 9
    Hsien-Chung Yu, Kung-Hung Lin, Ping-I Hsu, Feng-Woei Tsay, Huay-Min Wang, Tzung-Jiun Tsai, Kwok-Hung Lai, Real-World Application of the Roadmap Model in Chronic Hepatitis B Patients with Telbivudine Therapy, Clinical Therapeutics, 2013, 35, 9, 1386

    CrossRef

  10. 10
    H. You, J. Jia, Telbivudine treatment in chronic hepatitis B: experience from China, Journal of Viral Hepatitis, 2013, 20,
  11. 11
    Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han, Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B, Clinical and Molecular Hepatology, 2013, 19, 1, 82

    CrossRef

  12. You have free access to this content12
    Hong Ma, Jidong Jia, Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue, Liver International, 2013, 33,
  13. 13
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  14. 14
    Peter Karayiannis, Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis, Scientifica, 2012, 2012, 1

    CrossRef

  15. 15
    Chao Wei Hsu, You Chen Chao, Chuan Mo Lee, Ting Tsung Chang, Yi Cheng Chen, Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24, BMC Gastroenterology, 2012, 12, 1, 178

    CrossRef

  16. 16
    Miriam T. Levy, Preventing Perinatal Transmission of HBV: An Australian Perspective, Current Hepatitis Reports, 2012, 11, 4, 206

    CrossRef

  17. 17
    Cheng Wang, Rong Fan, Jian Sun, Jinlin Hou, Prevention and management of drug resistant hepatitis B virus infections, Journal of Gastroenterology and Hepatology, 2012, 27, 9
  18. 18
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef